Cargando…

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer

The drug therapy for non-small cell lung cancer (NSCLC) have always been issues of poisonous side effect, acquired drug resistance and narrow applicable population. In this study, we built a novel network analysis method (difference- correlation- enrichment- causality- node), which was based on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yuquan, Zhou, Lu, Zhang, Chuanfen, Guo, Minzhang, Xia, Liang, Tang, Zhenying, Liu, Yi, Deng, Senyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691970/ https://www.ncbi.nlm.nih.gov/pubmed/37864031 http://dx.doi.org/10.1038/s41388-023-02866-5

Ejemplares similares

Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
por: Gan, Fanyi, et al.
Publicado: (2022)

Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
por: Zhang, Chuanfen, et al.
Publicado: (2022)

A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma
por: Bai, Yuquan, et al.
Publicado: (2020)

A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022)

Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer
por: Bai, Yuquan, et al.
Publicado: (2022)

Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway
por: Cheng, Jiahan, et al.
Publicado: (2022)

Artificial intelligence in cancer target identification and drug discovery
por: You, Yujie, et al.
Publicado: (2022)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis
por: Peng, Zhiyu, et al.
Publicado: (2021)

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)

Ectopic bronchogenic cyst arising from the diaphragm: a rare case report and literature review
por: Tang, Juan, et al.
Publicado: (2021)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Discovery of Small Molecule Bak Activator for Lung Cancer Therapy
por: Park, Dongkyoo, et al.
Publicado: (2021)

Therapeutic target discovery using Boolean network attractors: improvements of kali
por: Poret, Arnaud, et al.
Publicado: (2018)

HAase-sensitive dual-targeting irinotecan liposomes enhance the therapeutic efficacy of lung cancer in animals
por: Zhang, Liang, et al.
Publicado: (2018)

The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer
por: Moonmuang, Sutpirat, et al.
Publicado: (2023)

Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis
por: Wang, Yunguan, et al.
Publicado: (2020)

Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma
por: Cao, Danfeng, et al.
Publicado: (2022)

Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications
por: Castillo, Jonathan, et al.
Publicado: (2017)

Discovery of therapeutic targets of quercetin for endometrial carcinoma patients infected with COVID-19 through network pharmacology
por: Li, Kehan, et al.
Publicado: (2023)

Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer
por: Li, Piaopiao, et al.
Publicado: (2022)

A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration
por: Wu, Xinhui, et al.
Publicado: (2022)

Deep transcriptome annotation enables the discovery and functional characterization of cryptic small proteins
por: Samandi, Sondos, et al.
Publicado: (2017)

Single-cell transcriptomics reveals the drivers and therapeutic targets of lymph node metastasis in lung adenocarcinoma
por: Ji, Xin, et al.
Publicado: (2023)

Structure-guided Discovery of Dual-recognition Chemibodies
por: Cheng, Alan C., et al.
Publicado: (2018)

Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics
por: Wu, Lei, et al.
Publicado: (2023)

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
por: Chrienova, Zofia, et al.
Publicado: (2022)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Response to the combination use of pazopanib with olaratumab in a patient with lung-metastatic embryonal rhabdomyosarcoma: a case report
por: Xing, Tuo, et al.
Publicado: (2021)

Association between certain non–small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death‐ligand 1 inhibition
por: Liang, Wenhua, et al.
Publicado: (2019)

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
por: Cheng, Yuan, et al.
Publicado: (2021)

Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
por: Abdelsalam, Esraa A., et al.
Publicado: (2022)

The BioAssay network and its implications to future therapeutic discovery
por: Zhang, Jintao, et al.
Publicado: (2011)

Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang, Xiang, et al.
Publicado: (2019)

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice
por: Park, Min Hee, et al.
Publicado: (2022)

Multiplex immunofluorescence and single‐cell transcriptomic profiling reveal the spatial cell interaction networks in the non‐small cell lung cancer microenvironment
por: Peng, Haoxin, et al.
Publicado: (2023)

Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation
por: Zhao, Zhenying, et al.
Publicado: (2013)

Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network
por: Liang, Huisheng, et al.
Publicado: (2021)

Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis
por: Zhao, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vl1lj5l3bbifmirt2u65233evl